No abstract

embolization (GroupB). ELIIp incidence was evaluated by CEUS at 6-12-month Results: In P1, AAA-sac coil embolization was performed in 61 cases (M:96.7%;Age:72.2AE8years;AAA diameter:57AE7mm). The mean AAATV and FSV were 156AE60cc and 46AE25cc, respectively. The median number and mean concentration of coils were 4.5AE1.4 and 0.17coil/cc (range:0.02-1.20). Incidence of ELIIp was 29% and 23% at 6 and 12-month, respectively. Fourteen patients (23%) were clustered in Group1 and 47 (77%) in Group2. The results of P1 are summarised in Table I. Cutoff of CCoil¼0.17coil/cm 3 was identified by Roc-Curve [Area¼.758(.639-.877), p¼.001]. ELIIp was significantly related to the presence of CCoil<0.17coil/cc (100%vs68%, Group1 e Group2 respectively, p¼.014). In P2, there were 40 patients (29%) in GroupA, and 98 (71%) in GroupB. GroupA had significantly higher number of coils implanted than GroupB (10.3AE3.4 vs 4.6AE1.4 respectively, p£.001). ELIIp were significantly reduced in GroupA compared with GroupB at 6-12-month (5%vs23.5%, p¼.01 and 5%vs20.6%, p¼.02, respectively).

No abstract

prospectively recorded in a certified institutional registry. A retrospective analysis of the registry was performed, and 103 visceral vessels treated with Gore VBX in 28 patients between July 2018 and December 2019 were found. Perioperative results were analyzed in terms of technical success, VBX-related adjunctive procedures, 30-day patency, and reinterventions. The follow-up program consisted of a computed tomography angiography scan at 1 month and yearly thereafter and duplex ultrasound examination at 3 months and every 6 months thereafter. Followup results were analyzed in terms of bridging stent-related patency, complications, and reinterventions.Results: The indication for intervention was a thoracoabdominal aneurysm in 18 cases, a juxtarenal dilation in 5 patients, a pararenal aneurysm in 3 patients, a proximal para-anastomotic aneurysm after open aortic reconstruction in 1 case, and a short-neck (<5 mm) aneurysm in another patient. All patients underwent an elective intervention. In 19 cases, a fenestrated graft was placed, and in 4, a branched graft; in the remaining 5 cases, a combination of both fenestrations and branches was the configuration of choice. Overall, 55 renal arteries, 25 superior mesenteric arteries, and 23 celiac trunks were treated with Gore VBX. Technical success was 100%. Additional stent placement into a target visceral vessel to extend the distal landing zone was required in five vessels (4.9%). The asymptomatic occlusion (1/103 [0.9%]) of the VBX for a celiac trunk affected by subocclusive stenosis preoperatively was recorded 20 days after the procedure and was left untreated. No perioperative reinterventions were performed. Median duration of follow-up was 4.4 months (range, 1-14 months); no occlusion was documented. Reintervention rate was 0.9% (1/103); a type IC endoleak from a celiac trunk was diagnosed 3 months after the procedure and was treated with distal placement of another VBX stent graft into the celiac trunk, with complete resolution of the endoleak.Conclusions: In our experience of 103 target visceral vessels, the Gore VBX stent graft guaranteed satisfying perioperative results, providing optimal delivery and adaptability into target vessels. Further investigation is needed to evaluate follow-up results, especially in terms of resistance to the continuous aortic remodeling and the pinching load related to vessel pulsatility.

No abstract